In studies on colon cancer, the indoleamine 2,3-dioxygenase 1 (IDO1) transcript was identified as the target for miR-448 to regulate the antitumor function of CD8+ T cells [255]. This evidence concerns the gene IDO1 and colonic neoplasm.